US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist

4.580
-0.162-3.41%

Close Nov 29 13:00 ET

4.580
0.0000.00%

Post 17:01 ET

13.86MMarket Cap-33P/E (TTM)

Traws Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-156.79%-11.48M

-119.42%-9.85M

2.62%-4.42M

-10.05%-17.93M

-14.06%-4.43M

-14.59%-4.47M

-6.55%-4.49M

-5.75%-4.54M

16.39%-16.29M

8.93%-3.88M

Net income from continuing operations

-78.84%-8.48M

-2,797.48%-123.14M

13.71%-4.98M

0.08%-18.95M

22.80%-4.18M

12.21%-4.74M

-5.62%-4.25M

-40.10%-5.78M

-17.33%-18.96M

-44.00%-5.42M

Depreciation and amortization

-60.00%2K

0.00%4K

33.33%4K

14.29%16K

0.00%4K

66.67%5K

0.00%4K

0.00%3K

0.00%14K

0.00%4K

Other non cash items

--0

----

Change In working capital

-3,422.11%-3.35M

-781.43%-4.56M

-75.14%222K

-120.28%-301K

-148.42%-582K

-107.98%-95K

-18.85%-517K

288.79%893K

141.30%1.48M

256.92%1.2M

-Change in receivables

-210,200.00%-2.1M

--0

1,200.00%11K

--0

---1K

--0

1,100.00%12K

-111.11%-1K

-200.00%-1K

-Change in prepaid assets

135.89%375K

-122.45%-22K

131.54%76K

-450.22%-1.26M

-113.11%-72K

-388.67%-1.05M

111.02%98K

3.98%-241K

-143.21%-229K

62.91%549K

-Change in payables and accrued expense

-254.86%-1.56M

-702.51%-4.48M

-82.85%202K

-39.20%1.17M

-163.94%-454K

15.07%1.01M

-208.98%-558K

805.39%1.18M

149.44%1.93M

178.02%710K

-Change in other current assets

----

--0

----

--9K

--0

-Change in other working capital

0.00%-57K

0.00%-56K

0.00%-226K

0.00%-56K

0.00%-57K

0.00%-56K

0.00%-226K

0.00%-56K

Cash from discontinued investing activities

Operating cash flow

-156.79%-11.48M

-119.42%-9.85M

2.62%-4.42M

-10.05%-17.93M

-14.06%-4.43M

-14.59%-4.47M

-6.55%-4.49M

-5.75%-4.54M

16.39%-16.29M

8.93%-3.88M

Investing cash flow

Cash flow from continuing investing activities

-14K

Net PPE purchase and sale

----

---14K

--0

----

--0

Net business purchase and sale

--0

----

--0

----

Cash from discontinued investing activities

Investing cash flow

--0

----

---14K

--0

---14K

----

--0

Financing cash flow

Cash flow from continuing financing activities

Net common stock issuance

--0

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

----

--0

----

Net cash flow

Beginning cash position

-43.20%16.89M

-52.10%16.39M

-46.28%20.82M

-29.62%38.76M

-40.76%25.24M

-36.11%29.73M

-32.59%34.22M

-29.62%38.76M

189.46%55.07M

-28.23%42.61M

Current changes in cash

-155.99%-11.48M

111.11%499K

2.62%-4.42M

-10.14%-17.95M

-14.06%-4.43M

-14.95%-4.48M

-6.55%-4.49M

-5.75%-4.54M

-145.17%-16.29M

9.67%-3.88M

Effect of exchange rate changes

--0

-200.00%-3K

-216.67%-7K

152.63%10K

-75.00%7K

90.00%-2K

95.00%-1K

185.71%6K

32.14%-19K

450.00%28K

End cash Position

-78.57%5.41M

-43.20%16.89M

-52.10%16.39M

-46.28%20.82M

-40.76%25.24M

-36.11%29.73M

-32.59%34.22M

-29.62%38.76M

Free cash flow

-155.99%-11.48M

-119.42%-9.85M

2.62%-4.42M

-10.14%-17.95M

-14.06%-4.43M

-14.95%-4.48M

-6.55%-4.49M

-5.75%-4.54M

16.39%-16.29M

8.93%-3.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-156.79%-11.48M	-119.42%-9.85M	2.62%-4.42M	-10.05%-17.93M	-14.06%-4.43M	-14.59%-4.47M	-6.55%-4.49M	-5.75%-4.54M	16.39%-16.29M	8.93%-3.88M
Net income from continuing operations	-78.84%-8.48M	-2,797.48%-123.14M	13.71%-4.98M	0.08%-18.95M	22.80%-4.18M	12.21%-4.74M	-5.62%-4.25M	-40.10%-5.78M	-17.33%-18.96M	-44.00%-5.42M
Depreciation and amortization	-60.00%2K	0.00%4K	33.33%4K	14.29%16K	0.00%4K	66.67%5K	0.00%4K	0.00%3K	0.00%14K	0.00%4K
Other non cash items	--0	----	----	----	----	----	----	----	----	----
Change In working capital	-3,422.11%-3.35M	-781.43%-4.56M	-75.14%222K	-120.28%-301K	-148.42%-582K	-107.98%-95K	-18.85%-517K	288.79%893K	141.30%1.48M	256.92%1.2M
-Change in receivables	-210,200.00%-2.1M	--0	--0	1,200.00%11K	--0	---1K	--0	1,100.00%12K	-111.11%-1K	-200.00%-1K
-Change in prepaid assets	135.89%375K	-122.45%-22K	131.54%76K	-450.22%-1.26M	-113.11%-72K	-388.67%-1.05M	111.02%98K	3.98%-241K	-143.21%-229K	62.91%549K
-Change in payables and accrued expense	-254.86%-1.56M	-702.51%-4.48M	-82.85%202K	-39.20%1.17M	-163.94%-454K	15.07%1.01M	-208.98%-558K	805.39%1.18M	149.44%1.93M	178.02%710K
-Change in other current assets	----	----	----	--0	--0	----	----	----	--9K	--0
-Change in other working capital	0.00%-57K	0.00%-57K	0.00%-56K	0.00%-226K	0.00%-56K	0.00%-57K	0.00%-57K	0.00%-56K	0.00%-226K	0.00%-56K
Cash from discontinued investing activities
Operating cash flow	-156.79%-11.48M	-119.42%-9.85M	2.62%-4.42M	-10.05%-17.93M	-14.06%-4.43M	-14.59%-4.47M	-6.55%-4.49M	-5.75%-4.54M	16.39%-16.29M	8.93%-3.88M
Investing cash flow
Cash flow from continuing investing activities	0			-14K	0	-14K			0	0
Net PPE purchase and sale	----	----	----	---14K	--0	----	----	----	--0	--0
Net business purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	--0	----	----	---14K	--0	---14K	----	----	--0	--0
Financing cash flow
Cash flow from continuing financing activities	0					0
Net common stock issuance	--0	----	----	----	----	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	----	----	----	----	--0	----	----	----	----
Net cash flow
Beginning cash position	-43.20%16.89M	-52.10%16.39M	-46.28%20.82M	-29.62%38.76M	-40.76%25.24M	-36.11%29.73M	-32.59%34.22M	-29.62%38.76M	189.46%55.07M	-28.23%42.61M
Current changes in cash	-155.99%-11.48M	111.11%499K	2.62%-4.42M	-10.14%-17.95M	-14.06%-4.43M	-14.95%-4.48M	-6.55%-4.49M	-5.75%-4.54M	-145.17%-16.29M	9.67%-3.88M
Effect of exchange rate changes	--0	-200.00%-3K	-216.67%-7K	152.63%10K	-75.00%7K	90.00%-2K	95.00%-1K	185.71%6K	32.14%-19K	450.00%28K
End cash Position	-78.57%5.41M	-43.20%16.89M	-52.10%16.39M	-46.28%20.82M	-46.28%20.82M	-40.76%25.24M	-36.11%29.73M	-32.59%34.22M	-29.62%38.76M	-29.62%38.76M
Free cash flow	-155.99%-11.48M	-119.42%-9.85M	2.62%-4.42M	-10.14%-17.95M	-14.06%-4.43M	-14.95%-4.48M	-6.55%-4.49M	-5.75%-4.54M	16.39%-16.29M	8.93%-3.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data